1 Study Coverage 1.1 Autacoids and Related Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Autacoids and Related Drugs Market Size Growth Rate by Type 1.4.2 Polypeptides 1.4.3 Decarboxylated Amino Acids 1.2.4 Eicosanoids 1.3 Market by Application 1.3.1 Global Autacoids and Related Drugs Market Size Growth Rate by Application 1.3.2 Allergies 1.3.3 Inflammation 1.3.4 Gastric Acid Secretion 1.3.5 Neuroendocrine Regulation 1.3.6 Chronic Pain 1.3.7 Cardiovascular Diseases 1.3.8 Gastrointestinal Diseases 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Autacoids and Related Drugs Sales Estimates and Forecasts 2016-2027 2.2 Global Autacoids and Related Drugs Revenue Estimates and Forecasts 2016-2027 2.3 Global Autacoids and Related Drugs Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Autacoids and Related Drugs Regions by Sales 2.4.1 Global Top Autacoids and Related Drugs Regions by Sales (2016-2021) 2.4.2 Global Top Autacoids and Related Drugs Regions by Sales (2022-2027) 2.5 Global Top Autacoids and Related Drugs Regions by Revenue 2.5.1 Global Top Autacoids and Related Drugs Regions by Revenue (2016-2021) 2.5.2 Global Top Autacoids and Related Drugs Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Autacoids and Related Drugs Sales by Manufacturers 3.1.1 Global Top Autacoids and Related Drugs Manufacturers by Sales (2016-2021) 3.1.2 Global Top Autacoids and Related Drugs Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Autacoids and Related Drugs Sales in 2020 3.2 Global Autacoids and Related Drugs Revenue by Manufacturers 3.2.1 Global Top Autacoids and Related Drugs Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Autacoids and Related Drugs Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Autacoids and Related Drugs Revenue in 2020 3.3 Global Autacoids and Related Drugs Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Autacoids and Related Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Autacoids and Related Drugs Sales by Type 4.1.1 Global Autacoids and Related Drugs Historical Sales by Type (2016-2021) 4.1.2 Global Autacoids and Related Drugs Forecasted Sales by Type (2022-2027) 4.1.3 Global Autacoids and Related Drugs Sales Market Share by Type (2016-2027) 4.2 Global Autacoids and Related Drugs Revenue by Type 4.2.1 Global Autacoids and Related Drugs Historical Revenue by Type (2016-2021) 4.2.2 Global Autacoids and Related Drugs Forecasted Revenue by Type (2022-2027) 4.2.3 Global Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) 4.3 Global Autacoids and Related Drugs Price by Type 4.3.1 Global Autacoids and Related Drugs Price by Type (2016-2021) 4.3.2 Global Autacoids and Related Drugs Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Autacoids and Related Drugs Sales by Application 5.1.1 Global Autacoids and Related Drugs Historical Sales by Application (2016-2021) 5.1.2 Global Autacoids and Related Drugs Forecasted Sales by Application (2022-2027) 5.1.3 Global Autacoids and Related Drugs Sales Market Share by Application (2016-2027) 5.2 Global Autacoids and Related Drugs Revenue by Application 5.2.1 Global Autacoids and Related Drugs Historical Revenue by Application (2016-2021) 5.2.2 Global Autacoids and Related Drugs Forecasted Revenue by Application (2022-2027) 5.2.3 Global Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) 5.3 Global Autacoids and Related Drugs Price by Application 5.3.1 Global Autacoids and Related Drugs Price by Application (2016-2021) 5.3.2 Global Autacoids and Related Drugs Price Forecast by Application (2022-2027) 6 North America 6.1 North America Autacoids and Related Drugs Market Size by Type 6.1.1 North America Autacoids and Related Drugs Sales by Type (2016-2027) 6.1.2 North America Autacoids and Related Drugs Revenue by Type (2016-2027) 6.2 North America Autacoids and Related Drugs Market Size by Application 6.2.1 North America Autacoids and Related Drugs Sales by Application (2016-2027) 6.2.2 North America Autacoids and Related Drugs Revenue by Application (2016-2027) 6.3 North America Autacoids and Related Drugs Market Size by Country 6.3.1 North America Autacoids and Related Drugs Sales by Country (2016-2027) 6.3.2 North America Autacoids and Related Drugs Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Autacoids and Related Drugs Market Size by Type 7.1.1 Europe Autacoids and Related Drugs Sales by Type (2017-2027) 7.1.2 Europe Autacoids and Related Drugs Revenue by Type (2017-2027) 7.2 Europe Autacoids and Related Drugs Market Size by Application 7.2.1 Europe Autacoids and Related Drugs Sales by Application (2017-2027) 7.2.2 Europe Autacoids and Related Drugs Revenue by Application (2017-2027) 7.3 Europe Autacoids and Related Drugs Market Size by Country 7.3.1 Europe Autacoids and Related Drugs Sales by Country (2017-2027) 7.3.2 Europe Autacoids and Related Drugs Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Autacoids and Related Drugs Market Size by Type 8.1.1 Asia Pacific Autacoids and Related Drugs Sales by Type (2018-2027) 8.1.2 Asia Pacific Autacoids and Related Drugs Revenue by Type (2018-2027) 8.2 Asia Pacific Autacoids and Related Drugs Market Size by Application 8.2.1 Asia Pacific Autacoids and Related Drugs Sales by Application (2018-2027) 8.2.2 Asia Pacific Autacoids and Related Drugs Revenue by Application (2018-2027) 8.3 Asia Pacific Autacoids and Related Drugs Market Size by Region 8.3.1 Asia Pacific Autacoids and Related Drugs Sales by Region (2018-2027) 8.3.2 Asia Pacific Autacoids and Related Drugs Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Autacoids and Related Drugs Market Size by Type 9.1.1 Latin America Autacoids and Related Drugs Sales by Type (2019-2027) 9.1.2 Latin America Autacoids and Related Drugs Revenue by Type (2019-2027) 9.2 Latin America Autacoids and Related Drugs Market Size by Application 9.2.1 Latin America Autacoids and Related Drugs Sales by Application (2019-2027) 9.2.2 Latin America Autacoids and Related Drugs Revenue by Application (2019-2027) 9.3 Latin America Autacoids and Related Drugs Market Size by Country 9.3.1 Latin America Autacoids and Related Drugs Sales by Country (2019-2027) 9.3.2 Latin America Autacoids and Related Drugs Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Autacoids and Related Drugs Market Size by Type 6.1.1 Middle East and Africa Autacoids and Related Drugs Sales by Type (2016-2027) 6.1.2 Middle East and Africa Autacoids and Related Drugs Revenue by Type (2016-2027) 6.2 Middle East and Africa Autacoids and Related Drugs Market Size by Application 6.2.1 Middle East and Africa Autacoids and Related Drugs Sales by Application (2016-2027) 6.2.2 Middle East and Africa Autacoids and Related Drugs Revenue by Application (2016-2027) 6.3 Middle East and Africa Autacoids and Related Drugs Market Size by Country 6.3.1 Middle East and Africa Autacoids and Related Drugs Sales by Country (2016-2027) 6.3.2 Middle East and Africa Autacoids and Related Drugs Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Bedford Laboratories 11.1.1 Bedford Laboratories Corporation Information 11.1.2 Bedford Laboratories Overview 11.1.3 Bedford Laboratories Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Bedford Laboratories Autacoids and Related Drugs Product Description 11.1.5 Bedford Laboratories Related Developments 11.2 Bristol-Myers Squibb 11.2.1 Bristol-Myers Squibb Corporation Information 11.2.2 Bristol-Myers Squibb Overview 11.2.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Bristol-Myers Squibb Autacoids and Related Drugs Product Description 11.2.5 Bristol-Myers Squibb Related Developments 11.3 Fresenius 11.3.1 Fresenius Corporation Information 11.3.2 Fresenius Overview 11.3.3 Fresenius Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Fresenius Autacoids and Related Drugs Product Description 11.3.5 Fresenius Related Developments 11.4 Abbott Laboratories 11.4.1 Abbott Laboratories Corporation Information 11.4.2 Abbott Laboratories Overview 11.4.3 Abbott Laboratories Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Abbott Laboratories Autacoids and Related Drugs Product Description 11.4.5 Abbott Laboratories Related Developments 11.5 Sanofi 11.5.1 Sanofi Corporation Information 11.5.2 Sanofi Overview 11.5.3 Sanofi Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Sanofi Autacoids and Related Drugs Product Description 11.5.5 Sanofi Related Developments 11.6 AstraZeneca 11.6.1 AstraZeneca Corporation Information 11.6.2 AstraZeneca Overview 11.6.3 AstraZeneca Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 AstraZeneca Autacoids and Related Drugs Product Description 11.6.5 AstraZeneca Related Developments 11.1 Bedford Laboratories 11.1.1 Bedford Laboratories Corporation Information 11.1.2 Bedford Laboratories Overview 11.1.3 Bedford Laboratories Autacoids and Related Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Bedford Laboratories Autacoids and Related Drugs Product Description 11.1.5 Bedford Laboratories Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Autacoids and Related Drugs Value Chain Analysis 12.2 Autacoids and Related Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Autacoids and Related Drugs Production Mode & Process 12.4 Autacoids and Related Drugs Sales and Marketing 12.4.1 Autacoids and Related Drugs Sales Channels 12.4.2 Autacoids and Related Drugs Distributors 12.5 Autacoids and Related Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Autacoids and Related Drugs Industry Trends 13.2 Autacoids and Related Drugs Market Drivers 13.3 Autacoids and Related Drugs Market Challenges 13.4 Autacoids and Related Drugs Market Restraints 14 Key Findings in The Global Autacoids and Related Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Autacoids and Related Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Polypeptides Table 3. Major Manufacturers of Decarboxylated Amino Acids Table 4. Major Manufacturers of Eicosanoids Table 5. Global Autacoids and Related Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Autacoids and Related Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Autacoids and Related Drugs Sales by Region (2016-2021) & (K Units) Table 8. Global Autacoids and Related Drugs Sales Market Share by Region (2016-2021) Table 9. Global Autacoids and Related Drugs Sales by Region (2016-2021) & (K Units) Table 10. Global Autacoids and Related Drugs Sales Market Share by Region (2022-2027) Table 11. Global Autacoids and Related Drugs Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Autacoids and Related Drugs Revenue Market Share by Region (2016-2021) Table 13. Global Autacoids and Related Drugs Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Autacoids and Related Drugs Revenue Market Share by Region (2022-2027) Table 15. Global Autacoids and Related Drugs Sales by Manufacturers (2016-2021) & (K Units) Table 16. Global Autacoids and Related Drugs Sales Share by Manufacturers (2016-2021) Table 17. Global Autacoids and Related Drugs Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Autacoids and Related Drugs Revenue Share by Manufacturers (2016-2021) Table 19. Autacoids and Related Drugs Price by Manufacturers 2016-2021 (USD/Pcs) Table 20. Global Autacoids and Related Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Autacoids and Related Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autacoids and Related Drugs as of 2020) Table 22. Autacoids and Related Drugs Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Autacoids and Related Drugs Product Offered Table 24. Date of Manufacturers Enter into Autacoids and Related Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units) Table 27. Global Autacoids and Related Drugs Sales by Type (2022-2027) & (K Units) Table 28. Global Autacoids and Related Drugs Sales Share by Type (2016-2021) Table 29. Global Autacoids and Related Drugs Sales Share by Type (2022-2027) Table 30. Global Autacoids and Related Drugs Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Autacoids and Related Drugs Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Autacoids and Related Drugs Revenue Share by Type (2016-2021) Table 33. Global Autacoids and Related Drugs Revenue Share by Type (2022-2027) Table 34. Autacoids and Related Drugs Price by Type (2016-2021) & (USD/Pcs) Table 35. Global Autacoids and Related Drugs Price Forecast by Type (2022-2027) & (USD/Pcs) Table 36. Global Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units) Table 37. Global Autacoids and Related Drugs Sales by Application (2022-2027) & (K Units) Table 38. Global Autacoids and Related Drugs Sales Share by Application (2016-2021) Table 39. Global Autacoids and Related Drugs Sales Share by Application (2022-2027) Table 40. Global Autacoids and Related Drugs Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Autacoids and Related Drugs Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Autacoids and Related Drugs Revenue Share by Application (2016-2021) Table 43. Global Autacoids and Related Drugs Revenue Share by Application (2022-2027) Table 44. Autacoids and Related Drugs Price by Application (2016-2021) & (USD/Pcs) Table 45. Global Autacoids and Related Drugs Price Forecast by Application (2022-2027) & (USD/Pcs) Table 46. North America Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units) Table 47. North America Autacoids and Related Drugs Sales by Type (2022-2027) & (K Units) Table 48. North America Autacoids and Related Drugs Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Autacoids and Related Drugs Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units) Table 51. North America Autacoids and Related Drugs Sales by Application (2022-2027) & (K Units) Table 52. North America Autacoids and Related Drugs Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Autacoids and Related Drugs Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 55. North America Autacoids and Related Drugs Sales by Country (2022-2027) & (K Units) Table 56. North America Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Autacoids and Related Drugs Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units) Table 59. Europe Autacoids and Related Drugs Sales by Type (2022-2027) & (K Units) Table 60. Europe Autacoids and Related Drugs Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Autacoids and Related Drugs Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units) Table 63. Europe Autacoids and Related Drugs Sales by Application (2022-2027) & (K Units) Table 64. Europe Autacoids and Related Drugs Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Autacoids and Related Drugs Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 67. Europe Autacoids and Related Drugs Sales by Country (2022-2027) & (K Units) Table 68. Europe Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Autacoids and Related Drugs Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units) Table 71. Asia Pacific Autacoids and Related Drugs Sales by Type (2022-2027) & (K Units) Table 72. Asia Pacific Autacoids and Related Drugs Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Autacoids and Related Drugs Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units) Table 75. Asia Pacific Autacoids and Related Drugs Sales by Application (2022-2027) & (K Units) Table 76. Asia Pacific Autacoids and Related Drugs Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Autacoids and Related Drugs Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Autacoids and Related Drugs Sales by Region (2016-2021) & (K Units) Table 79. Asia Pacific Autacoids and Related Drugs Sales by Region (2022-2027) & (K Units) Table 80. Asia Pacific Autacoids and Related Drugs Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Autacoids and Related Drugs Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units) Table 83. Latin America Autacoids and Related Drugs Sales by Type (2022-2027) & (K Units) Table 84. Latin America Autacoids and Related Drugs Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Autacoids and Related Drugs Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units) Table 87. Latin America Autacoids and Related Drugs Sales by Application (2022-2027) & (K Units) Table 88. Latin America Autacoids and Related Drugs Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Autacoids and Related Drugs Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 91. Latin America Autacoids and Related Drugs Sales by Country (2022-2027) & (K Units) Table 92. Latin America Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Autacoids and Related Drugs Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Autacoids and Related Drugs Sales by Type (2016-2021) & (K Units) Table 95. Middle East and Africa Autacoids and Related Drugs Sales by Type (2022-2027) & (K Units) Table 96. Middle East and Africa Autacoids and Related Drugs Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Autacoids and Related Drugs Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Autacoids and Related Drugs Sales by Application (2016-2021) & (K Units) Table 99. Middle East and Africa Autacoids and Related Drugs Sales by Application (2022-2027) & (K Units) Table 100. Middle East and Africa Autacoids and Related Drugs Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Autacoids and Related Drugs Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 103. Middle East and Africa Autacoids and Related Drugs Sales by Country (2022-2027) & (K Units) Table 104. Middle East and Africa Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Autacoids and Related Drugs Revenue by Country (2022-2027) & (US$ Million) Table 106. Bedford Laboratories Corporation Information Table 107. Bedford Laboratories Description and Major Businesses Table 108. Bedford Laboratories Autacoids and Related Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 109. Bedford Laboratories Autacoids and Related Drugs Product Table 110. Bedford Laboratories Recent Developments Table 111. Bristol-Myers Squibb Corporation Information Table 112. Bristol-Myers Squibb Description and Major Businesses Table 113. Bristol-Myers Squibb Autacoids and Related Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 114. Bristol-Myers Squibb Autacoids and Related Drugs Product Table 115. Bristol-Myers Squibb Recent Developments Table 116. Fresenius Corporation Information Table 117. Fresenius Description and Major Businesses Table 118. Fresenius Autacoids and Related Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 119. Fresenius Autacoids and Related Drugs Product Table 120. Fresenius Recent Developments Table 121. Abbott Laboratories Corporation Information Table 122. Abbott Laboratories Description and Major Businesses Table 123. Abbott Laboratories Autacoids and Related Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 124. Abbott Laboratories Autacoids and Related Drugs Product Table 125. Abbott Laboratories Recent Developments Table 126. Sanofi Corporation Information Table 127. Sanofi Description and Major Businesses Table 128. Sanofi Autacoids and Related Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 129. Sanofi Autacoids and Related Drugs Product Table 130. Sanofi Recent Developments Table 131. AstraZeneca Corporation Information Table 132. AstraZeneca Description and Major Businesses Table 133. AstraZeneca Autacoids and Related Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 134. AstraZeneca Autacoids and Related Drugs Product Table 135. AstraZeneca Recent Developments Table 136. Key Raw Materials Lists Table 137. Raw Materials Key Suppliers Lists Table 138. Autacoids and Related Drugs Distributors List Table 139. Autacoids and Related Drugs Customers List Table 140. Autacoids and Related Drugs Market Trends Table 141. Autacoids and Related Drugs Market Drivers Table 142. Autacoids and Related Drugs Market Challenges Table 143. Autacoids and Related Drugs Market Restraints Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Autacoids and Related Drugs Product Picture Figure 2. Global Autacoids and Related Drugs Market Share by Type in 2020 & 2027 Figure 3. Polypeptides Product Picture Figure 4. Decarboxylated Amino Acids Product Picture Figure 5. Eicosanoids Product Picture Figure 6. Global Autacoids and Related Drugs Sales Market Share by Application in 2020 & 2027 Figure 7. Allergies Figure 8. Inflammation Figure 9. Gastric Acid Secretion Figure 10. Neuroendocrine Regulation Figure 11. Chronic Pain Figure 12. Cardiovascular Diseases Figure 13. Gastrointestinal Diseases Figure 14. Autacoids and Related Drugs Report Years Considered Figure 15. Global Autacoids and Related Drugs Sales 2016-2027 (K Units) Figure 16. Global Autacoids and Related Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Autacoids and Related Drugs Revenue 2016-2027 (US$ Million) Figure 18. Global Autacoids and Related Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 19. Global Autacoids and Related Drugs Sales Market Share by Region (2016-2021) Figure 20. Global Autacoids and Related Drugs Sales Market Share by Region (2022-2027) Figure 21. North America Autacoids and Related Drugs Sales YoY (2016-2027) & (K Units) Figure 22. North America Autacoids and Related Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 23. Europe Autacoids and Related Drugs Sales YoY (2016-2027) & (K Units) Figure 24. Europe Autacoids and Related Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 25. Asia-Pacific Autacoids and Related Drugs Sales YoY (2016-2027) & (K Units) Figure 26. Asia-Pacific Autacoids and Related Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 27. Latin America Autacoids and Related Drugs Sales YoY (2016-2027) & (K Units) Figure 28. Latin America Autacoids and Related Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 29. Middle East & Africa Autacoids and Related Drugs Sales YoY (2016-2027) & (K Units) Figure 30. Middle East & Africa Autacoids and Related Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 31. The Top 10 and Top 5 Players Market Share by Autacoids and Related Drugs Sales in 2020 Figure 32. The Top 10 and Top 5 Players Market Share by Autacoids and Related Drugs Revenue in 2020 Figure 33. Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 34. Global Autacoids and Related Drugs Sales Market Share by Type (2016-2027) Figure 35. Global Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) Figure 36. Global Autacoids and Related Drugs Sales Market Share by Application (2016-2027) Figure 37. Global Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) Figure 38. North America Autacoids and Related Drugs Sales Market Share by Type (2016-2027) Figure 39. North America Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) Figure 40. North America Autacoids and Related Drugs Sales Market Share by Application (2016-2027) Figure 41. North America Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) Figure 42. North America Autacoids and Related Drugs Sales Share by Country (2016-2027) Figure 43. North America Autacoids and Related Drugs Revenue Share by Country (2016-2027) Figure 44. U.S. Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 45. Canada Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 46. Europe Autacoids and Related Drugs Sales Market Share by Type (2016-2027) Figure 47. Europe Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) Figure 48. Europe Autacoids and Related Drugs Sales Market Share by Application (2016-2027) Figure 49. Europe Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) Figure 50. Europe Autacoids and Related Drugs Sales Share by Country (2016-2027) Figure 51. Europe Autacoids and Related Drugs Revenue Share by Country (2016-2027) Figure 52. Germany Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 53. France Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 54. U.K. Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 55. Italy Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 56. Russia Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 57. Asia Pacific Autacoids and Related Drugs Sales Market Share by Type (2016-2027) Figure 58. Asia Pacific Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) Figure 59. Asia Pacific Autacoids and Related Drugs Sales Market Share by Application (2016-2027) Figure 60. Asia Pacific Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) Figure 61. Asia Pacific Autacoids and Related Drugs Sales Share by Region (2016-2027) Figure 62. Asia Pacific Autacoids and Related Drugs Revenue Share by Region (2016-2027) Figure 63. China Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 64. Japan Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 65. South Korea Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 66. India Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 67. Australia Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 68. Taiwan Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 69. Indonesia Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 70. Thailand Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 71. Malaysia Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 72. Philippines Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 73. Latin America Autacoids and Related Drugs Sales Market Share by Type (2016-2027) Figure 74. Latin America Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) Figure 75. Latin America Autacoids and Related Drugs Sales Market Share by Application (2016-2027) Figure 76. Latin America Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) Figure 77. Latin America Autacoids and Related Drugs Sales Share by Country (2016-2027) Figure 78. Latin America Autacoids and Related Drugs Revenue Share by Country (2016-2027) Figure 79. Mexico Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 80. Brazil Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 81. Argentina Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 82. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Type (2016-2027) Figure 83. Middle East and Africa Autacoids and Related Drugs Revenue Market Share by Type (2016-2027) Figure 84. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Application (2016-2027) Figure 85. Middle East and Africa Autacoids and Related Drugs Revenue Market Share by Application (2016-2027) Figure 86. Middle East and Africa Autacoids and Related Drugs Sales Share by Country (2016-2027) Figure 87. Middle East and Africa Autacoids and Related Drugs Revenue Share by Country (2016-2027) Figure 88. Turkey Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 89. Saudi Arabia Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 90. U.A.E Autacoids and Related Drugs Revenue (2016-2027) & (US$ Million) Figure 91. Autacoids and Related Drugs Value Chain Figure 92. Autacoids and Related Drugs Production Process Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed

Bedford Laboratories Bristol-Myers Squibb Fresenius Abbott Laboratories Sanofi AstraZeneca